News & Media

Renaissance and Mitacs partner to test precision yeast-based RNAi technologies

Released

Renaissance BioScience Corp. partners with Mitacs in a million-dollar project to test precision yeast-based  RNAi technologies for environmentally friendly agricultural biopesticides and medical biotherapeutics

Vancouver, Canada, January 23, 2019 — Renaissance BioScience Corp. (RBSC), a leading global microorganism bioengineering company, is pleased to announce a new partnership with Mitacs, the University of British Columbia and the University of Manitoba for a three-year, Cdn$975,000 multi-investigator research and development project.

Mitacs, a not-for-profit organization that fosters growth and innovation in Canada, will provide matching funding for the RBSC project to extend its R&D of an engineered, yeast-based RNA interference (RNAi) production and delivery platform across multiple insect and animal models. This will test and confirm the proof-of-concept utility for the system to augment or replace industrial chemical pesticides in many different agricultural applications, as well as form the basis of an animal and human biotherapeutics production and delivery platform.

“We are pleased to work with Mitacs as a co-funding partner in this exciting project to further develop and test our yeast-based RNAi production and delivery platform, initially in biocontrol and biotherapeutic applications,” said Dr. Matthew Dahabieh, Chief Science Officer, RBSC. “There is a significant potential global market, for these environmentally friendly, RNAi-based technologies, especially in the crop protection and animal agricultural sectors. Up until now, the efficient and cost-effective delivery of RNAi in the field has always been a barrier to adoption. Yeast, however, as a stable, non-toxic and well-understood industrial organism, is an excellent platform to deliver on the promise of RNAi as a biocontrol and medical biotherapeutics agent.”

Alejandro Adem, Mitacs’ CEO and Scientific Director, added, “Yeast-based RNAi therapeutics and biocontrol is an exciting emerging area of research in which Canada can become a world leader. Mitacs is excited to partner on this research and leverage Renaissance’s expertise, while helping to expand Canada’s intellectual capacity in this newly emerging field.”

About Mitacs 

Mitacs is a not-for-profit organization that fosters growth and innovation in Canada by solving business challenges with research solutions from the best academic institutions at home and around the world. For 20 years Mitacs has built an ecosystem of partners that helps businesses achieve breakthrough results, supports essential talent acquisition for growing companies, and prepares researchers for rewarding industry-focused careers.

About Renaissance BioScience Corp.

Renaissance BioScience Corp., based in Vancouver, Canada, is a privately held biological engineering company that develops innovative, market-ready, functional microorganisms for the global food, beverage, nutrition, biofuel, agricultural and pharmaceutical industries. The wholly owned commercial subsidiaries of Renaissance BioScience Corp. include Renaissance Yeast Inc., which commercializes hydrogen sulfide-preventing wine yeast; Renaissance Ingredients Inc., which commercializes acrylamide-reducing yeast; and Bright Brewers Yeast Inc., which commercializes beer yeast technologies. Detailed information about the Renaissance group of companies can be accessed at www.renaissancebioscience.com .

 

For further information or to arrange interviews, please contact:

Steve Campbell
Campbell & Company Strategies Inc.
Communications and Public Relations
Vancouver, BC, Canada
Tel.: 01 604 888-5267
Email: renaissance@ccom-pr.com